logo

For the Inventor, By the Inventor

Chelsea, MA, United States of America

Civitas Therapeutics, Inc.

USPTO Granted Patents = 30

% Expired Patents = 23.3



Trademarks = 1

Forward Citations = 262

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Michael M Lipp (13 out of 31 patents)

silverMedal Richard P Batycky (12 out of 25 patents)

bronzeMedal Ernest D Penachio (6 out of 6 patents)

4.  Jeffrey S Hrkach (6 out of 24 patents)

5.  Jake P Ganem (6 out of 13 patents)

6.  Abhijit Kamerkar (5 out of 5 patents)

7.  Raymond T Bartus (4 out of 13 patents)

8.  Kevin D Kee (4 out of 4 patents)

9.  Blair C Jackson (4 out of 6 patents)

10.  David J Bennett (4 out of 5 patents)

11.  Dwaine F Emerich (4 out of 9 patents)

12.  Giovanni Caponetti (3 out of 26 patents)

13.  Elliot Ehrich (3 out of 14 patents)

14.  Colleen Ellwanger (3 out of 3 patents)

15.  Brian Noble (3 out of 4 patents)


Core Competencies:
Pulmonary Delivery
Inhaler Devices
Levodopa Formulations
Therapeutic Powders
Dosator Apparatus
Aerosol Delivery
Pharmaceutical Powders
Porous Particles
Triptan Powders
Epinephrine Inhalation
Capsule Fillers
Inter-Patient Variability

30 patents:

1. 10238607 - Dosator apparatus for filling a capsule with dry powder (2019-03-26),
2. 10034857 - Triptan powders for pulmonary delivery (2018-07-31),
3. 9717866 - Powder inhaler devices (2017-08-01),
4. 9642812 - Dosator apparatus for filling a capsule with dry powder (2017-05-09),
5. 9539211 - Ultra low density pulmonary powders (2017-01-10),
6. 9468728 - Powder inhaler devices (2016-10-18),
7. 9393210 - Capsules containing high doses of levodopa for pulmonary use (2016-07-19),
8. 9387169 - Rapamycin powders for pulmonary delivery (2016-07-12),
9. 9333174 - Use of simple amino acids to form porous particles (2016-05-10),
10. D755367 - Indicator for an inhaler (2016-05-03),
11. D752734 - Inhaler grip (2016-03-29),
12. 9295661 - Methods for reducing inter-patient variability of levodopa plasma concentrations (2016-03-29),
13. D752204 - Indicator for an inhaler (2016-03-22),
14. 9155699 - Pulmonary delivery for levodopa (2015-10-13),
15. 8945612 - Capsules containing high doses of levodopa for pulmonary use (2015-02-03),
Company Overview
Civitas Therapeutics, Inc., based in Chelsea, MA, is a biotechnology company focused on developing innovative therapies for neurological disorders. The organization specializes in advanced drug delivery systems, particularly utilizing its proprietary technology to enhance the efficacy of medications for conditions such as Parkinson's disease. By leveraging its expertise in formulation and device design, Civitas aims to improve patient outcomes and quality of life through targeted treatment solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Civitas Therapeutics, Inc. USPTO Patent Assignee Logo
30 Patents

#1 in Chelsea, MA

#671 in Massachusetts

#11,279 in US

#21,912 in the World

Chelsea, MA (US)
Chelsea, MA, United States of America

Civitas Therapeutics, Inc.

Forward Citations = 262

36 inventors:

goldMedal Michael M Lipp (13 out of 31 patents)

silverMedal Richard P Batycky (12 out of 25 patents)

bronzeMedal Ernest D Penachio (6 out of 6 patents)

4.  Jeffrey S Hrkach (6 out of 24 patents)

5.  Jake P Ganem (6 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Civitas Therapeutics, Inc.. Retrieved from https://idiyas.com/company/civitas-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…